… Molnupiravir has been shown to be effective in preventing … with mild-to-moderate COVID-19.
In this study, we evaluate the efficacy and safety of molnupiravir in Indian patients with mild …

… Authorization in three countries for the treatment of mild COVID-19. The aim of this systematic
review was to find out the safety and efficacy of Molnupiravir in SARS-COV-2 infections. …

… and safety of molnupiravir in patients with COVID-19. … Molnupiravir is first oral antiviral drug
to demonstrate a significant benefit in reducing hospitalization or death in mild COVID-19 and …

… of COVID-19. This study evaluates the efficacy and safety of molnupiravir in addition to …
standard-of-care (SOC) for the treatment of non-hospitalized patients with mild COVID-19. …

… assess the efficacy and safety of molnupiravir in patients with mild or moderate COVID-19. …
thus far of the efficacy and safety of molnupiravir in treating patients with mild-to-moderate …

… Molnupiravir and nirmatrelvir were the first available oral antivirals (OAs) active against …
on the efficacy and safety of OAs during the omicron surge of the COVID-19 pandemic. Among …

… The analysis concluded that both preclinical and clinical studies have shown the effectiveness
and safety of molnupiravir as an antiviral therapy [23]. However, most RCTs were done on …

… Population: Participants will be recruited among patients who are prescribed molnupiravir
for treatment of non-severe COVID19 disease at sites participating in this study. Study …

… Seven out of eight studies on outpatients included patients with mild COVID-19 defined
according to the study protocols (WHO scale 2–3). Another small Phase 3 single-centre study …

… has been approved for import registration for the treatment of mild-to-moderate COVID-19
patients with advanced severe high-risk factors, such as advanced age, obesity or overweight, …